About Sentrimed
Sentrimed is a private company based in Mullica Hill, New Jersey, incorporated in 2023 in Delaware. It has reported $750,000 raised in two offerings on Form D since March 2024. Its chief executive is William Ragatz.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 8, 2026 | May 13, 2026 | $250,000of $1.0M target | 1 | $250K | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Feb 28, 2024 | Mar 7, 2024 | $500,000of $1.5M target | 1 | $500K | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, two offerings | $750,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Sentrimed's Form D filed May 13, 2026.
AR
Arye Rosen
Vice President
JG
Jack Goldberg
Chief Medical Officer and director
MY
GG
WR
CL
BG
Bradley Galer
Director
TD
Tabbetha Dobbins
Director
Earlier filings also listed Mari Rhodehamel Yin (executive officer and director, last listed Mar 2024).
Sources
- SECSentrimed, Inc. filing history
- CompanyPrivacy policy
- CompanyManagement team
- CompanyBoard of directors